« Back
Novel Engineered Basic Fibroblast Growth Factor Improves Stability and Enables Improved Cell Culture Outcomes
Poster Title: Novel Engineered Basic Fibroblast Growth Factor Improves Stability and Enables Improved Cell Culture Outcomes
Submitted on 03 Jan 2019
Author(s): Brittany Balhouse, Diana Navarro, Richard Josephson, and Matthew Dallas
Affiliations: Thermo Fisher Scientific
This poster was presented at 2018 ASCB|EMBO Annual Meeting
Poster Views: 823
View poster »

Poster Information
Abstract: Basic fibroblast growth factor (bFGF, also known as FGF2) is widely used in vitro for the maintenance and stimulation of a variety of cells. However, use of native bFGF in cell biology is limited by the fact that bFGF rapidly degrades at physiological temperatures; we demonstrated < 20% activity of native bFGF after 72 hours. We have addressed this problem with an engineered form of bFGF, named Heat Stable bFGF (HS bFGF), which is stable at 37 degrees Celsius. HS bFGF maintains > 90% homology with the native protein and > 80% activity after 72 hours in standard mammalian culture conditions. We have used HS bFGF to enhance expansion of multipotent human and rat neural stem cells (NSCs), using a reduced bFGF concentration and a more user-friendly workflow respectively. Doubling time in both models was also reduced by approximately 30% with the use of HS bFGF versus native bFGF. Critically, differentiation of NSCs into the neuronal, astrocyte-, and oligodendrocyte-lineages was comparable between HS bFGF and native bFGF. The downstream differentiation demonstrates the ability of HS bFGF to be completely removed from the culture when desired. HS bFGF was also tested in the stimulation of MCF7 human breast adenocarcinoma cells in three-dimensional (3D) culture. MCF7 spheroids were cultured in bFGF supplemented serum-free medium for 8 days without media changes so that spheroid morphology was undisturbed. Spheroids cultured in HS bFGF were perceptibly larger than those in native bFGF, starting just three days after seeding and continuing throughout the culture period. HS bFGF enhanced spheroid growth by almost 20% more than the native protein, as measured by PrestoBlue® assay. Because there was no need to change the media, we were also able to observe morphological changes to the spheroids that likely would have been impossible to document with a standard media change regimen. These data reinforce the idea that bFGF is a mitotic agent for MCF7 cells, a point which has previously been debated in the literature, and confirm that HS bFGF can provide stable stimulation in long-term culture. Taken together, these data show HS bFGF has broad applicability in cell biology and will be a valuable technology for a variety of applications moving forward. HS bFGF not only allows for reduced concentrations of bFGF to be used, but also enables a more user-friendly workflow for cell culture maintenance.Summary: HS bFGF: Engineered for greater stability
References: Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Graphene oxide modulates the steroidogenic and apoptotic pathway in a buffalo granulosa cell model
E.L. Lyngdoh, Varij Nayan, M. Vashisht, S. Kumari, T. Bhatia, Jasmer, S. Pawaria, A. Bhardwaj, P. Kumar, P. Sikka, S.K. Onteru, D. Singh

Microbial deterioration of works of art: An interdisciplinary approach in the Criminology Museum of National & Kapodistrian University of Athens
Eleni Tziamourani, Maria Stefanidou, Georgios Panagiaris

The Optimum Food for AIDS Patients’ Health Support
Abu_bakir Imad hamdi

Streamlining Biologics Development with the Expi Expression Systems
Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Kenneth Thompson, Maya Yovcheva, Sara Barnes, Mark Bundy, Melissa Cross, Katy Irvin, Joaquín Canay, Mary Reynolds, Natasha Lucki, Henry Chiou, Andrew Campbell, Jonathan Zmuda

ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda